Biogen Inc.BIIB
NasdaqGS•Healthcare•Drug Manufacturers - General
Analyze revenue and earnings growth — the core drivers of long-term shareholder returns.
TTM revenue reached $9.94B, growing 1.2% year-over-year. TTM net income stood at $1.37B (7.3% contraction). Quarterly EBITDA was $583.20M and operating income was $378.80M. Consistent revenue and earnings growth are the primary drivers of long-term shareholder returns. Analyze BIIB growth trends across revenue, EBITDA, operating income, and net income.
Revenue and earnings growth across quarters